240 related articles for article (PubMed ID: 25820698)
1. Indolo[3,2-c]quinoline G-quadruplex stabilizers: a structural analysis of binding to the human telomeric G-quadruplex.
Lavrado J; Ohnmacht SA; Correia I; Leitão C; Pisco S; Gunaratnam M; Moreira R; Neidle S; Santos DJ; Paulo A
ChemMedChem; 2015 May; 10(5):836-49. PubMed ID: 25820698
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, G-quadruplex stabilisation, docking studies, and effect on cancer cells of indolo[3,2-b]quinolines with one, two, or three basic side chains.
Lavrado J; Borralho PM; Ohnmacht SA; Castro RE; Rodrigues CM; Moreira R; dos Santos DJ; Neidle S; Paulo A
ChemMedChem; 2013 Oct; 8(10):1648-61. PubMed ID: 23960016
[TBL] [Abstract][Full Text] [Related]
3. KRAS oncogene repression in colon cancer cell lines by G-quadruplex binding indolo[3,2-c]quinolines.
Lavrado J; Brito H; Borralho PM; Ohnmacht SA; Kim NS; Leitão C; Pisco S; Gunaratnam M; Rodrigues CM; Moreira R; Neidle S; Paulo A
Sci Rep; 2015 Apr; 5():9696. PubMed ID: 25853628
[TBL] [Abstract][Full Text] [Related]
4. 5-N-methylated quindoline derivatives as telomeric g-quadruplex stabilizing ligands: effects of 5-N positive charge on quadruplex binding affinity and cell proliferation.
Lu YJ; Ou TM; Tan JH; Hou JQ; Shao WY; Peng D; Sun N; Wang XD; Wu WB; Bu XZ; Huang ZS; Ma DL; Wong KY; Gu LQ
J Med Chem; 2008 Oct; 51(20):6381-92. PubMed ID: 18821749
[TBL] [Abstract][Full Text] [Related]
5. Targeting KRAS Oncogene in Colon Cancer Cells with 7-Carboxylate Indolo[3,2-b]quinoline Tri-Alkylamine Derivatives.
Brito H; Martins AC; Lavrado J; Mendes E; Francisco AP; Santos SA; Ohnmacht SA; Kim NS; Rodrigues CM; Moreira R; Neidle S; Borralho PM; Paulo A
PLoS One; 2015; 10(5):e0126891. PubMed ID: 26024321
[TBL] [Abstract][Full Text] [Related]
6. Studies on the binding of 5-N-methylated quindoline derivative to human telomeric G-quadruplex.
Xu W; Tan JH; Chen SB; Hou JQ; Li D; Huang ZS; Gu LQ
Biochem Biophys Res Commun; 2011 Mar; 406(3):454-8. PubMed ID: 21333628
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and in vitro antiproliferative activity of new 11-aminoalkylamino-substituted 5H- and 6H-indolo[2,3-b]quinolines; structure-activity relationships of neocryptolepines and 6-methyl congeners.
Wang L; Switalska M; Mei ZW; Lu WJ; Takahara Y; Feng XW; El-Sayed Iel-T; Wietrzyk J; Inokuchi T
Bioorg Med Chem; 2012 Aug; 20(15):4820-9. PubMed ID: 22748378
[TBL] [Abstract][Full Text] [Related]
8. Tandem application of ligand-based virtual screening and G4-OAS assay to identify novel G-quadruplex-targeting chemotypes.
Musumeci D; Amato J; Zizza P; Platella C; Cosconati S; Cingolani C; Biroccio A; Novellino E; Randazzo A; Giancola C; Pagano B; Montesarchio D
Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt B):1341-1352. PubMed ID: 28130159
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of analogues of 10H-indolo[3,2-b]quinoline as G-quadruplex stabilising ligands and potential inhibitors of the enzyme telomerase.
Guyen B; Schultes CM; Hazel P; Mann J; Neidle S
Org Biomol Chem; 2004 Apr; 2(7):981-8. PubMed ID: 15034620
[TBL] [Abstract][Full Text] [Related]
10. Phenanthroline-bis-oxazole ligands for binding and stabilization of G-quadruplexes.
Medeiros-Silva J; Guédin A; Salgado GF; Mergny JL; Queiroz JA; Cabrita EJ; Cruz C
Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt B):1281-1292. PubMed ID: 27865994
[TBL] [Abstract][Full Text] [Related]
11. Structural basis for telomeric G-quadruplex targeting by naphthalene diimide ligands.
Collie GW; Promontorio R; Hampel SM; Micco M; Neidle S; Parkinson GN
J Am Chem Soc; 2012 Feb; 134(5):2723-31. PubMed ID: 22280460
[TBL] [Abstract][Full Text] [Related]
12. Dimeric aryl-substituted imidazoles may inhibit ALT cancer by targeting the multimeric G-quadruplex in telomere.
Hu MH; Lin XT; Liu B; Tan JH
Eur J Med Chem; 2020 Jan; 186():111891. PubMed ID: 31759730
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and in vitro cytotoxic effect of 6-amino-substituted 11H- and 11Me-indolo[3,2-c]quinolines.
Wang N; Świtalska M; Wu MY; Imai K; Ngoc TA; Pang CQ; Wang L; Wietrzyk J; Inokuchi T
Eur J Med Chem; 2014 May; 78():314-23. PubMed ID: 24686018
[TBL] [Abstract][Full Text] [Related]
14. Towards the Development of Structure-Selective G-Quadruplex-Binding Indolo[3,2-b]quinolines.
Funke A; Dickerhoff J; Weisz K
Chemistry; 2016 Feb; 22(9):3170-81. PubMed ID: 26808655
[TBL] [Abstract][Full Text] [Related]
15. Targeting multiple G-quadruplex-forming DNA sequences: Design, biophysical and biological evaluations of indolo-naphthyridine scaffold derivatives.
Catalano R; Moraca F; Amato J; Cristofari C; Rigo R; Via LD; Rocca R; Lupia A; Maruca A; Costa G; Catalanotti B; Artese A; Pagano B; Randazzo A; Sissi C; Novellino E; Alcaro S
Eur J Med Chem; 2019 Nov; 182():111627. PubMed ID: 31446246
[TBL] [Abstract][Full Text] [Related]
16. Combining 1,3-Ditriazolylbenzene and Quinoline to Discover a New G-Quadruplex-Interactive Small Molecule Active against Cancer Stem-Like Cells.
Mendes E; Cadoni E; Carneiro F; Afonso MB; Brito H; Lavrado J; Dos Santos DJVA; Vítor JB; Neidle S; Rodrigues CMP; Paulo A
ChemMedChem; 2019 Jul; 14(14):1325-1328. PubMed ID: 31162877
[TBL] [Abstract][Full Text] [Related]
17. Rational design of acridine-based ligands with selectivity for human telomeric quadruplexes.
Sparapani S; Haider SM; Doria F; Gunaratnam M; Neidle S
J Am Chem Soc; 2010 Sep; 132(35):12263-72. PubMed ID: 20718414
[TBL] [Abstract][Full Text] [Related]
18. C-11 diamino cryptolepine derivatives NSC748392, NSC748393, and NSC748394: anticancer profile and G-quadruplex stabilization.
Lavrado J; Reszka AP; Moreira R; Neidle S; Paulo A
Bioorg Med Chem Lett; 2010 Dec; 20(23):7042-5. PubMed ID: 20952194
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and Telomeric G-Quadruplex-Stabilizing Ability of Macrocyclic Hexaoxazoles Bearing Three Side Chains.
Ma Y; Iida K; Sasaki S; Hirokawa T; Heddi B; Phan AT; Nagasawa K
Molecules; 2019 Jan; 24(2):. PubMed ID: 30642002
[TBL] [Abstract][Full Text] [Related]
20. Exploring the chemical space of G-quadruplex binders: discovery of a novel chemotype targeting the human telomeric sequence.
Di Leva FS; Zizza P; Cingolani C; D'Angelo C; Pagano B; Amato J; Salvati E; Sissi C; Pinato O; Marinelli L; Cavalli A; Cosconati S; Novellino E; Randazzo A; Biroccio A
J Med Chem; 2013 Dec; 56(23):9646-54. PubMed ID: 24256368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
